ArticleBiomolecules & therapeutics2025

Andrographolide as a Multi-Target Therapeutic Agent in Diabetic Nephropathy: Insights into STAT3/PI3K/Akt Pathway Modulation.

Yuan Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.